Catalyst Wire Dossier Catalyst Wire Dossier

Cyclophosphamide (oral)

Cyclophosphamide
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cyclophosphamide (oral), covering 2017-02-10 to 2021-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]

See pricing